Form 4 for ABT Abbott Laboratories
Accepted 2024-02-27 00:00:00 ET · period of report 2024-02-23 · accession 0001415889-24-005576 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-27 | 2024-02-23 | ABT | Wainer Andrea F | EVP | S - Sale+OE | $120.00 | -12.5K | 78.7K | -14% | -$1.50M |
| D | 2024-02-27 | 2024-02-23 | ABT | Wainer Andrea F | EVP | M - OptEx | $59.94 | +12.5K | 91.2K | +16% | +$749.2K |
| D | 2024-02-27 | 2024-02-23 | ABT | Wainer Andrea F | EVP | M - OptEx | $0.00 | -12.5K | 34.4K | -27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2024-02-23 | S | D | 12,500 | $120.00 | 78,704 | D | — | — | |
| 2 | Common | Common shares without par value | 2024-02-23 | M | A | 12,500 | $59.94 | 91,204 | D | — | — | |
| 3 | Derivative | Option (right to buy) | 2024-02-23 | M | D | 12,500 | $0.00 | 34,449 | D | $59.94 · 2021-02-16 to 2028-02-15 | 12,500 Common Shares | (F1) Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |